Aurobindo Pharma gains on receiving USFDA approval for Sildenafil Tablets

23 Nov 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 849.60, up by 17.45 points or 2.10% from its previous closing of Rs. 832.15 on the BSE.

The scrip opened at Rs. 841.10 and has touched a high and low of Rs. 851.00 and Rs. 840.05 respectively. So far 51,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 860.80 on 29-Oct-2015 and a 52 week low of Rs. 490.50 on 26-Feb-2015.

Last one week high and low of the scrip stood at Rs. 851.00 and Rs. 808.30 respectively. The current market cap of the company is Rs. 49,613.00 crore.

The promoters holding in the company stood at 53.92% while Institutions and Non-Institutions held 34.97% and 11.11% respectively.

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Tablets, 20 mg. This product is expected to be launched by Q4FY 2015-16. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) REVATIO (sildenafil citrate) Tablets 20 mg of Pfizer, Inc.

Sildenafil Tablets are used in the treatment of pulmonary arterial hypertension (high blood pressure in the lungs). The approved product has an estimated market size of $80 million for the twelve months ending September 2015.

This is the 51st ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products. The pharma major now has a total of 219 ANDA approvals (190 Final approvals including 10 from Aurolife Pharma LLC and 29 Tentative approvals) from USFDA.

Aurobindo Pharma, headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, Japan PMDA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.


Aurobindo Pharma Share Price

1176.65 -40.80 (-3.35%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×